SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-201368
Filing Date
2014-05-15
Accepted
2014-05-15 16:57:07
Documents
7
Period of Report
2014-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d728248d8k.htm 8-K 19895
2 EX-1.1 d728248dex11.htm EX-1.1 212273
3 EX-5.1 d728248dex51.htm EX-5.1 10363
4 EX-99.1 d728248dex991.htm EX-99.1 6073
5 EX-99.2 d728248dex992.htm EX-99.2 5468
6 GRAPHIC g728248footer.jpg GRAPHIC 10964
7 GRAPHIC g728248header.jpg GRAPHIC 8299
  Complete submission text file 0001193125-14-201368.txt   282178
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 14848506
SIC: 8731 Services-Commercial Physical & Biological Research